The fight for ownership of the powerful gene-editing technique known as CRISPR-Cas9 is over, at least for now. A panel of judges at the U.S. Patent and Trademark Office ruled Feb. 15 in favor of the Broad Institute of the Massachusetts Institute of Technology and Harvard, despite the fact that the University of California, Berkeley, had pioneered the technique using less complex bacterial systems....